Selected companies are developing innovations in gene therapy, chronic condition management, and social isolation of the elderly.
A deal slump that started in Q3 of last year, has now increased for the second quarter in a row.
Teams from each company will spend three months in Los Angeles working closely with Cedars-Sinai mentors, including doctors, researchers and administrators.
These companies span direct-to-consumer goods, diagnostic devices, and remote patient monitoring in payer, provider and employer spaces.
The market is seemingly slowing down, but both companies see other reasons to be optimistic about digital health investment.
The cohort was selected by a pool of institutions, providers, and payors looking to form partnerships and solve challenges with digital health startups.
Put into dollars, that's $8B raised in 556 deals during the first 9 months of 2018, compared to $5.5B in 586 deals during the same period last year.
The program is designed to rapidly pilot technologies of NYC-based startups to advance healthcare, create jobs and strengthen City's health tech sector.
The digital health market is expected to surpass 2017 deal counts, with an increase in the percentage of mid- and late-stage deals.
The Q3 2018 was the biggest quarter yet, with $3.3B invested across 93 deals during the period.